DelphX Announces Grant of Stock Options
Rhea-AI Summary
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,200,000 stock options to eligible participants. The options, approved by the company's Board of Directors, have a two-year maturity and can be exercised at $0.25 per common share. This grant is part of DelphX's stock option plan and aims to align the interests of participants with those of shareholders, potentially incentivizing performance and retention.
Positive
- Grant of 1,200,000 stock options to eligible participants
- Options exercisable at $0.25 per common share
Negative
- None.
News Market Reaction
On the day this news was published, DPXCF declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Toronto, Ontario--(Newsfile Corp. - August 27, 2024) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products for the fixed income market, announces that its Board of Directors has approved the grant of 1,200,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/221301
FAQ
How many stock options did DelphX Capital Markets (DPXCF) grant on August 27, 2024?
What is the exercise price of the stock options granted by DelphX (DPXCF)?
What is the maturity period of the stock options granted by DelphX Capital Markets (DPXCF)?
On which stock exchanges is DelphX Capital Markets traded?
